UVEITIC MACULAR EDEMA
Clinical trials for UVEITIC MACULAR EDEMA explained in plain language.
Never miss a new study
Get alerted when new UVEITIC MACULAR EDEMA trials appear
Sign up with your email to follow new studies for UVEITIC MACULAR EDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection shows promise for blinding swelling in inflammatory eye disease
Disease control CompletedThis study tested an experimental drug called vamikibart, given as an eye injection, for people with uveitic macular edema — swelling in the back of the eye caused by inflammation. The goal was to see if it improves vision and reduces swelling better than a sham (fake) procedure.…
Matched conditions: UVEITIC MACULAR EDEMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 14:28 UTC
-
New eye injection shows promise for blinding swelling
Disease control CompletedThis study tested an experimental drug called vamikibart, given as an eye injection, for people with uveitic macular edema—a condition where the back of the eye swells due to inflammation. The trial involved 256 adults with active or inactive eye inflammation. The main goal was t…
Matched conditions: UVEITIC MACULAR EDEMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 14:26 UTC